Base editing is still a new technology. Alexis Komor is working to improve its efficiency, while lowering unwanted bystander edits. This occurs when a base editor not only edits the desired nucleobase, but edits surrounding bases as well. Komor’s lab has developed a way to minimize bystander edits.
William “Bill” Gentz has joined UC San Diego Moores Cancer Center as Associate Director of Administration. A seasoned research administration leader, Gentz brings more than two decades of experience supporting large research enterprises across leading academic institutions.
The future of cancer research doesn’t always begin in a lab or clinic. It can start much earlier — when a student first looks into a microscope or meets a mentor who helps them see a future in science.
A new discovery from UC San Diego researchers could enable easier treatment of high-grade serous ovarian cancer, the most common and aggressive form of ovarian cancer.
This UC San Diego chemical biologist is developing next-generation therapeutic platforms for diseases where conventional treatments have failed.
With up to $25 million from Cancer Grand Challenges, an international team led by UC San Diego professor Ludmil Alexandrov will unlock the secrets of DNA's "fingerprints."
Independent, March 10
The Hill, November 14
Keep up with all the latest from Moores Cancer Center. Subscribe to the newsletter today.
